A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
Reston, VA (October 13, 2025)--A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during ...
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
For real-time, in vivo screening of all single photon emission computed tomography (SPECT) isotopes, the γ-eye is the first and only SPECT scanner. The γ-eye is a comprehensive solution for all labs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results